a 2005

Skin lesions induced by bortezomib

POUR, Luděk, Roman HÁJEK, Zdeněk ADAM, Marta KREJČÍ, Andrea KŘIVANOVÁ et. al.

Basic information

Original name

Skin lesions induced by bortezomib

Name in Czech

Kožní léze po léčbě bortezomibem

Edition

10th Congress of EHA, 2005

Other information

Language

English

Type of outcome

Konferenční abstrakt

Field of Study

30200 3.2 Clinical medicine

Country of publisher

Italy

Confidentiality degree

není předmětem státního či obchodního tajemství

Organization unit

Faculty of Medicine

Keywords (in Czech)

mnohočetný myelom; bortezomib;prednison

Keywords in English

multiple myeloma;bortezomib;prednisone
Změněno: 10/2/2010 07:13, Mgr. Anna Potáčová, Ph.D.

Abstract

V originále

We report on six cases of skin lesions induced by bortezomib in patients treated for relapsed multiple myeloma. The folliculitis-like rash appeared in the second cycle of bortezomib therapy. Therapy with prednisone led to rapid resolution of the skin lesions. Prednisone 10 mg before each infusion of bortezomib was necessary to prevent recurrence of the rash while antihistamines alone were ineffective.

In Czech

V publikaci je popsán nález kožních lézí u pacientů s mnohočetným myelomem a preventivní účinek prednisonu.